Buy Superbolan 400 Dragon Pharma

Subtotal	$0.00
Shipping	$0.00
Total	$0.00

💉

Superbolan 400 Dragon Pharma

Test E 200 mg · Trenbolone E 100 mg · Drostanolone E 100 mg · advanced injectable blend

🧬

Class

Testosterone / 19-Nor / DHT

Injectable blend · 3 actives

⏱️

Ester / Active Life

Enanthate (all 3)

~7–10 day half-life

⚠️

Aromatization

Low–Mod + Progestin

AI + caber typically needed

🎯

User Level

Advanced

not for beginners

Typical Dose

400–600 mg

per week (1–1.5 mL)

Injection Frequency

E3.5D

twice weekly

Cycle Length

12–16 weeks

PCT 21 days after last pin

Lab Tested

Manufacturer	Dragon Pharma
Brand	Superbolan
Substance	Trenbolone Enanthate
Concentration	400 mg/ml
Pack Size	10 ml

Out of Stock

Description
FAQ

Superbolan 400 Dragon Pharma — Overview

Superbolan 400 Dragon Pharma is a three-compound injectable blend combining Testosterone Enanthate (200 mg/mL), Trenbolone Enanthate (100 mg/mL), and Drostanolone Enanthate (100 mg/mL) in a 10 mL vial at 400 mg/mL total. The blend stacks a full testosterone base with the anabolic and nutrient-partitioning properties of trenbolone and the anti-estrogenic, hardening effects of drostanolone (Masteron) — three compounds that are routinely combined in advanced lean-mass and recomposition cycles — pre-formulated into a single injection.

The practical advantage of a pre-mixed blend is dose convenience: one injection delivers a calibrated ratio of all three actives, eliminating the need to draw and mix separate vials. The trade-off is that the ratio is fixed — users who want to adjust individual compound proportions mid-cycle need standalone products. This page covers the pharmacology of each component, the combined effect profile, estrogen and prolactin management requirements, and a full PCT framework appropriate for a tren-inclusive cycle.

Testosterone Enanthate 200 mg Trenbolone Enanthate 100 mg Drostanolone Enanthate 100 mg 400 mg/mL · 10 mL vial Lean Bulk / Recomp Advanced

On this page

About the Compound
What Superbolan 400 Does
Who It's For
Superbolan 400 vs Alternatives
Combinations
Side Effects & Management
Bloodwork Monitoring
PCT
Practical Summary
References

About the Compound: Superbolan 400

Each milliliter of Superbolan 400 contains three pharmacologically distinct anabolic steroids, all on the enanthate ester for a matched half-life of approximately 7–10 days and a twice-weekly injection schedule:

Testosterone Enanthate 200 mg — the androgenic base; aromatizes to estradiol (E2) via the aromatase enzyme; provides the anabolic substrate for muscle protein synthesis, libido, and erythropoiesis; suppresses the HPG axis via negative feedback; at 200 mg/mL it constitutes half the total dose per injection, ensuring a meaningful testosterone contribution in any dose range from 400 to 800 mg/week
Trenbolone Enanthate 100 mg — 19-nor derived; does not aromatize; binds the androgen receptor with approximately five times the affinity of testosterone; progestogenic activity at the progesterone receptor creates prolactin risk distinct from estrogen; promotes nitrogen retention, IGF-1 upregulation, enhanced nutrient partitioning, and pronounced vascularity; the strongest androgen in the blend by receptor affinity
Drostanolone Enanthate 100 mg — DHT-derived; non-aromatizing; provides a partial anti-estrogenic effect through competitive SHBG displacement (freeing more testosterone while reducing the pool available for aromatization) and direct androgen receptor occupancy; contributes hardness, muscle density, and definition without water retention; its androgenic potency amplifies the androgenic load of the blend

The enanthate esters on all three compounds mean a single twice-weekly injection schedule covers the entire blend with minimal peak-to-trough fluctuation — a significant practical advantage over short-ester equivalents that require every-other-day or daily injections.

Total Concentration

400 mg/mL (10 mL vial = 4000 mg)

Per mL breakdown

Test E 200 mg + Tren E 100 mg + Drost E 100 mg

Ester / Half-life

Enanthate (all 3) · ~7–10 days

Injection Schedule

E3.5D (twice weekly)

Aromatization

Moderate — from test component only

Progestogenic

Yes — trenbolone component

Anti-estrogenic component

Yes — drostanolone via SHBG/aromatase

Vials for 12-week cycle at 400 mg/week

2 vials (4800 mg needed; 4000 mg/vial)

Vials for 12-week cycle at 600 mg/week

2 vials (7200 mg needed)

Vials for 16-week cycle at 600 mg/week

3 vials (9600 mg needed)

What Superbolan 400 Does

The blend produces effects from all three anabolic pathways simultaneously. The practical result is stronger than any single component would deliver at the same total milligram dose, because the mechanisms are additive and partially synergistic:

Lean mass accumulation — testosterone provides the primary anabolic stimulus via AR activation and IGF-1 upregulation; trenbolone amplifies nitrogen retention and adds its own potent AR-driven anabolism; the combination produces lean mass gains with minimal water retention, because drostanolone mitigates estrogen-driven water accumulation and trenbolone has no estrogenic activity
Nutrient partitioning and body composition — trenbolone's partitioning effect is unique among AAS: it simultaneously promotes muscle protein accretion and enhances fat oxidation, shifting the caloric environment toward lean tissue rather than fat storage; this makes Superbolan 400 effective at both moderate caloric surplus (lean bulk) and maintenance/slight deficit (recomp)
Hardness and vascularity — drostanolone reduces subcutaneous water by suppressing estrogen activity and displacing SHBG-bound testosterone; this produces the characteristic dry, hard, vascular appearance associated with DHT-derived compounds; the effect compounds with trenbolone's own anti-estrogenic effect and strong AR binding in muscle tissue
Strength — all three components contribute to strength through overlapping mechanisms: testosterone via ERK/PI3K and IGF-1 pathways, trenbolone via AR-mediated gene transcription, drostanolone via AR activation and reduced E2-mediated water-weight; strength gains typically precede visual body composition changes within the first 3–4 weeks
HPG axis suppression — all three compounds suppress endogenous testosterone production through HPG axis negative feedback; trenbolone is particularly suppressive and recovery requires a structured PCT; endogenous LH and FSH drop to near-zero on any tren-inclusive cycle; do not rely on HPG recovery without HCG and a SERM-based PCT protocol

Who It's For

What sets it apart: Superbolan 400 delivers the three most commonly combined advanced-cycle compounds — testosterone, trenbolone, and Masteron — in a single enanthate-ester injection at calibrated ratios. No other Dragon Pharma blend combines all three. The drostanolone component partially manages the estrogenic output of the testosterone component in situ, reducing but not eliminating the need for a standalone AI. The fixed 2:1:1 ratio (test:tren:mast) reflects a practical advanced cycle template, not an experimental combination — it mirrors how experienced users often structure standalone cycles of these three compounds.
Best scenario: experienced intermediate-to-advanced users running a 12–16 week lean bulk or recomposition cycle who are already familiar with managing trenbolone's side effect profile. Most suitable when the user has previously run at least one testosterone-only cycle and one tren-inclusive cycle separately, understands prolactin management, and has baseline bloodwork in place.
Choose something else instead: beginners and users who have never run trenbolone should not start with Superbolan 400 — the trenbolone component requires prior familiarity with its specific sides (night sweats, cardiovascular strain, prolactin elevation, neurotoxicity at high doses) and the blend format prevents reducing tren dose independently if sides appear; choose Enantat 250 for a first cycle. Users who want boldenone-based lean bulk without tren should use EQ 200 / Test E 200 Dragon Pharma. Female users should not use this blend due to both trenbolone's extreme androgenic potency and drostanolone's DHT-derived virilization risk.

Superbolan 400 vs Alternatives

Compound	Key Difference	Choose Superbolan 400 When	Choose Alternative When
Tren-Test 350 Dragon Pharma	Tren E 200 mg + Test E 150 mg per mL; no drostanolone component; tren-dominant ratio; stronger tren-to-test ratio than Superbolan 400	You want the anti-estrogenic and hardening benefit of Masteron built into the blend, and prefer a higher test-to-tren ratio	You want a tren-heavy cycle with minimal test and are comfortable adding separate drostanolone or AI to manage estrogen
Cut Mix 150 Dragon Pharma	Short-ester cutting blend (Tren Ace + Mast Prop + Test Prop); 150 mg/mL; EOD injection required; faster clearance and faster PCT start vs all-enanthate Superbolan 400	You prefer long-ester twice-weekly convenience and plan a 12+ week run	Pre-contest or time-limited cycle where fast estrogen and tren clearance on exit is a priority; willing to inject EOD
Masteron 200 Dragon Pharma	Standalone Drostanolone Enanthate 200 mg/mL; allows full independent dose control of drostanolone without fixed blend ratios	You want the full pre-formulated three-compound experience in one injection	You already run a tren + test base and want to add drostanolone at a higher dose (e.g. 400 mg/week mast) than Superbolan 400's fixed 100 mg/mL ratio provides
Parabolan 100 Dragon Pharma	Trenbolone Hexahydrobenzylcarbonate; longer active life than enanthate; typically used as a standalone tren option added to a test base; no drostanolone component	You need all three compounds in one injection at a twice-weekly schedule	You specifically want trenbolone hex for a single tren-focused addition to your existing cycle, or are running a long off-season cycle where Parabolan's extended half-life suits the programming

Combinations

Goal	Stack	Notes
Standard lean bulk	Superbolan 400 400–600 mg/week (E3.5D) + Aromasin Dragon Pharma 12.5 mg EOD + Caberlin (Cabergoline) 0.25–0.5 mg E3D	Foundational tren+test+mast cycle with the mandatory E2 and prolactin management in place; baseline bloodwork required before starting
Oral kick-start (weeks 1–4)	Superbolan 400 + Dianabol Dragon Pharma 30–40 mg/day for first 4 weeks	Oral kickstart bridges the 3–4 week lag before enanthate esters reach steady state; Dianabol amplifies early size and strength gains; liver protection recommended during oral use (Liv.52 or TUDCA); watch E2 closely — Dianabol adds significant aromatase substrate
Late-cycle hardener (weeks 10–16)	Superbolan 400 + Winstrol Injectable Dragon Pharma 50 mg/day final 6 weeks	Injectable Winstrol adds further dryness and hardness without E2 increase; combines well with the existing drostanolone in Superbolan 400 for a finishing effect; monitor lipids — stanozolol strongly suppresses HDL
GH / peptide augmentation	Superbolan 400 + Ipamorelin Dragon Pharma 200–300 mcg 2–3×/day	GH secretagogue adds IGF-1-driven recovery, joint support, and lean tissue quality on top of the AAS anabolic stimulus; no hormonal interaction with the blend; well tolerated alongside tren-inclusive cycles where joint dryness from low E2 can become uncomfortable
Recomp at maintenance calories	Superbolan 400 400 mg/week + moderate caloric maintenance + high protein (2.2–2.5 g/kg)	Trenbolone's partitioning effect makes Superbolan 400 effective at maintenance calories; muscle accrual and fat loss can occur simultaneously; this use case does not require an oral kickstart and benefits from stable insulin/cortisol management through diet consistency

Side Effects & Management

What May Occur	Background	How to Handle It
Estradiol elevation / gynecomastia	Testosterone Enanthate 200 mg/mL is the aromatizing component; at typical doses of 400–600 mg/week, test contribution is 200–300 mg/week; drostanolone partially offsets aromatization but does not replace an AI at this testosterone dose	Aromasin Dragon Pharma 12.5 mg EOD as standard; escalate to 25 mg EOD if E2 symptoms appear; do not crash E2 below range — low E2 with tren compounds libido and joint issues; check E2 at week 3–4 and adjust
Prolactin elevation (tren-related)	Trenbolone activates the progesterone receptor, triggering lactotroph upregulation and elevated prolactin; this is distinct from dopamine-pathway prolactin seen with 19-nor nandrolone; high prolactin causes sexual dysfunction, nipple sensitivity, and mood changes independent of E2 levels	Caberlin (Cabergoline) 0.25–0.5 mg twice weekly from week 1; do not wait for symptoms to appear with tren; prolactin is harder to reverse once elevated; check prolactin at baseline and week 4
Androgenic — acne, oily skin	Drostanolone is DHT-derived and does not convert further via 5α-reductase; trenbolone also does not 5α-reduce to a weaker metabolite; finasteride does not block the androgenic activity of either tren or mast; acne risk is real, particularly in androgen-sensitive individuals	Topical benzoyl peroxide or retinoid; severe cases: Accutane Dragon Pharma at low dose (10–20 mg/day); note: finasteride is not effective for tren or mast androgenic effects
Hair loss (androgenic alopecia)	Both trenbolone and drostanolone are highly androgenic at the scalp level and bypass 5α-reductase sensitivity — finasteride does not protect against their scalp androgenicity; predisposed individuals will experience accelerated recession; this is a genetic sensitivity issue, not dose-dependent in a linear way	Minoxidil Dragon Pharma topically to slow recession; finasteride is not useful here; realistic expectation management is important: predisposed users will see hair loss on this blend regardless of ancillaries
Cardiovascular — lipids and BP	Trenbolone is among the most cardiotoxic AAS per unit dose: it strongly suppresses HDL, may promote LVH, and raises resting blood pressure through aldosterone-independent mechanisms; testosterone contributes additional HDL suppression via hepatic lipase upregulation; drostanolone adds minimal independent cardiovascular load but does not protect against tren's effects	Monitor lipids and BP at baseline, week 6, and end of cycle; HDL below 30 mg/dL warrants cycle pause; Rosulip (Rosuvastatin) for lipid management if LDL is elevated; omega-3 fatty acids;BP management with Sartel (Telmisartan) or Amlip (Amlodipine) if persistent elevation above 140/90; cardio training at moderate intensity throughout cycle
Night sweats / insomnia / anxiety	Trenbolone-specific CNS effects: night sweats, vivid or disturbing dreams, sleep disruption, and mood volatility are well-documented user-reported effects without a fully characterized receptor mechanism; typically correlate with dose and peak plasma concentration	Consistent sleep hygiene; split dose E3.5D to reduce peak plasma spikes; reduce dose if insomnia is persistent; these effects resolve after discontinuation; they are not a sign of a medical emergency but significantly affect quality of life at higher doses
Tren cough (post-injection)	Short-lived coughing fit occurring seconds to minutes after injection; caused by a small amount of oil reaching systemic circulation and triggering pulmonary prostaglandin release; more common with trenbolone than other AAS; not dangerous but alarming	Inject slowly over 30–60 seconds; aspirate if preferred; the episode resolves within 1–2 minutes; no treatment needed; does not indicate incorrect injection placement in most cases

Bloodwork Monitoring

Lab	When to Test	Target & Action Threshold
Prolactin	Baseline; week 4; end of cycle	Target <20 ng/mL (within normal range); prolactin above 25 ng/mL with symptoms (nipple sensitivity, sexual dysfunction) warrants cabergoline dose increase; the most critical tren-specific marker — do not skip this test
Estradiol (E2)	Baseline; week 3–4; adjust AI; end of cycle	Target 20–40 pg/mL on-cycle; above 60 pg/mL with symptoms → increase AI dose; below 15 pg/mL → reduce AI dose; E2 control on Superbolan 400 is lower difficulty than pure high-dose test cycles due to masteron's partial anti-estrogenic effect
LH / FSH	Baseline; end of cycle; PCT week 4	Expected to be suppressed to near-zero on cycle; recovery to >2 IU/L by PCT week 4 indicates adequate HPG axis restart; tren's deep suppression makes post-cycle LH/FSH tracking essential for assessing PCT efficacy
Hematocrit / CBC	Baseline; week 6; end of cycle	Target hematocrit <52%; above 55% increases viscosity and cardiovascular risk; donate blood or reduce test dose if hematocrit is rising; testosterone drives erythropoiesis via EPO and direct erythroid progenitor stimulation
Lipid panel (HDL, LDL, total cholesterol)	Baseline; week 6; end of cycle	HDL target >40 mg/dL; tren will suppress HDL aggressively — HDL below 30 mg/dL warrants cycle review; LDL target <130 mg/dL; consider Rosuvastatin if LDL exceeds 160 mg/dL mid-cycle
Blood pressure	Baseline; weekly throughout cycle	Target <130/85 mmHg; above 140/90 consistently warrants antihypertensive support; tren raises BP through mechanisms independent of E2 and sodium retention; BP is the most frequently under-monitored parameter on tren cycles
Total testosterone	Baseline; mid-cycle (optional)	Documents suppression of endogenous production; on-cycle exogenous T will read elevated; useful for confirming HPG suppression pattern; primary value is the post-PCT recovery check (target >400 ng/dL by 8 weeks post-PCT)

PCT

Trenbolone produces deeper and more prolonged HPG suppression than testosterone alone. Any tren-inclusive cycle requires a structured SERM-based PCT with optional HCG pre-loading; relying on HPG self-recovery without PCT is not appropriate for this compound combination.

Phase	Protocol	Notes
End of cycle (last 2 weeks)	HCG 5000 IU Dragon Pharma 500–1000 IU every other day for 10 days while still using Superbolan 400	Pre-PCT HCG stimulates testicular Leydig cells before SERM initiation; particularly important after tren cycles due to deep LH suppression; do not continue HCG into the SERM phase (suppresses LH via negative feedback if overlapped)
PCT weeks 1–4 (start 21 days after last Superbolan 400 injection)	Nolvadex Dragon Pharma 40 mg/day weeks 1–2 → 20 mg/day weeks 3–4; plus Clomid Dragon Pharma 50 mg/day weeks 1–2 → 25 mg/day weeks 3–4	Dual SERM protocol recommended after tren cycles; Nolvadex blocks E2 at pituitary and breast tissue; Clomid additionally stimulates FSH via its own hypothalamic GnRH effect; the combination addresses the deeper suppression typical of trenbolone-inclusive cycles more effectively than either agent alone
PCT weeks 5–6 (if LH / FSH recovery is slow)	Continue Nolvadex 20 mg/day alone for an additional 2 weeks	Extend SERM use only if bloodwork at week 4 shows LH <2 IU/L; do not extend Clomid use beyond week 4 without compelling need (vision and mood side effects accumulate with prolonged Clomid use)
Post-PCT bloodwork (week 4–6 after stopping SERMs)	Total testosterone, LH, FSH, E2	Target total testosterone >400 ng/dL with normal LH/FSH confirms successful recovery; repeat Superbolan 400 cycle not recommended until testosterone and LH/FSH have fully normalized

Note on cabergoline timing: discontinue cabergoline at the end of the cycle, not during PCT. Prolactin normalizes naturally once tren is cleared (∼3–4 weeks post-last pin with enanthate ester). Continuing cabergoline during PCT unnecessarily suppresses prolactin below range. Recheck prolactin 4 weeks post-cycle if sexual dysfunction persists during PCT.

Practical Summary

Cabergoline from day 1 — do not wait for prolactin symptoms to appear; trenbolone activates the progesterone receptor and prolactin can rise silently before side effects present; 0.25–0.5 mg twice weekly throughout the cycle is the standard protocol
The drostanolone component reduces but does not eliminate the need for an AI — run Aromasin 12.5 mg EOD as a baseline and adjust based on week 3–4 E2 bloodwork; crashing E2 with tren compounds libido and sexual side effects
Finasteride provides no protection for tren- or mast-related androgenic effects on scalp and skin; it only blocks 5α-reduction of testosterone, which is a minor factor here; predisposed users should use topical Minoxidil and set realistic expectations
At 400 mg/week (1 mL/week), one 10 mL vial covers exactly 10 weeks; for a 12-week cycle, 2 vials are required; for a 16-week cycle at 600 mg/week, 3 vials are needed — plan purchases before cycle start
Start PCT 21 days after the last injection; pre-load with HCG in the final 10 days of the cycle; run dual SERM (Nolvadex + Clomid) for 4 weeks; bloodwork at PCT week 4 to confirm HPG axis recovery
Monitor blood pressure weekly — trenbolone raises BP through mechanisms that do not respond to AI or E2 management; cardiovascular discipline during a Superbolan 400 cycle is non-negotiable

Superbolan 400 by Dragon Pharma represents one of the most effective advanced-cycle blends available at steroidwarehouse.com — combining three compounds that advanced users routinely run together into a single, convenient enanthate-ester injection. Its fixed 2:1:1 testosterone-to-trenbolone-to-masteron ratio is practical for lean bulk and recomposition purposes and benefits from the anti-estrogenic offset that drostanolone provides within the blend itself. For athletes with prior tren experience, adequate ancillaries in place, and a commitment to regular bloodwork, Superbolan 400 is among the most versatile compounds in the injectable lineup at steroidwarehouse — producing lean, hard, and vascular muscle gains without the water retention associated with pure testosterone or mass blends.

References

Source	Topic	Link
New England Journal of Medicine / PubMed	Bhasin et al. 1996 — randomized controlled trial using 600 mg/week testosterone enanthate for 10 weeks, showing increased fat-free mass, muscle size, and strength, especially when combined with resistance training; foundational evidence for supraphysiologic androgen anabolic effects	Bhasin S, et al. (1996) ↗
NCBI Bookshelf / StatPearls	Anabolic steroids overview — synthetic testosterone-derived AAS pharmacology, androgen receptor mechanism, anabolic-androgenic effects, oral and injectable steroid classes, misuse patterns, monitoring, and adverse effect profile	StatPearls: Anabolic Steroids ↗
NCBI Bookshelf / Endotext	Androgen physiology and pharmacology — testosterone and androgen derivative mechanisms of action, androgen receptor activity, HPG axis suppression, 5α-reduction, estradiol aromatization, synthetic androgen pharmacology, and androgen misuse context	Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗
Steroids / PubMed	Donner et al. 2015 — rat study evaluating trenbolone effects on body composition, cardiometabolic risk factors, insulin sensitivity, and selected cardiovascular-system endpoints; useful for trenbolone-specific mechanistic context, but not direct human safety evidence	Donner DG, et al. (2015) ↗
Endocrinology / PubMed	Saartok et al. 1984 — relative binding affinity study comparing anabolic-androgenic steroids at androgen receptors in skeletal muscle and prostate, as well as sex hormone-binding globulin; supports receptor-binding context but does not prove anti-estrogenic effects directly	Saartok T, et al. (1984) ↗

How does Superbolan 400 work?

It combines Trenbolone, Testosterone, and Drostanolone to promote lean muscle and fat loss; see Mechanism of Action. It delivers dramatic results—monitor with labs.

What is Superbolan 400?

Superbolan 400 is an injectable steroid blend for lean muscle; see What is Superbolan 400. It's potent—consult professionals for safe use.

Is Superbolan 400 safe?

It's safe with proper dosing and monitoring, but side effects like anxiety or gynecomastia require management; see Side Effects. Consult professionals for safety.

What is Superbolan 400 used for?

It's used for lean muscle, strength, and fat loss in cutting or recomp; see Key Benefits. It suits advanced users—use with professional oversight.

When to take Superbolan 400?

Inject 400-800 mg weekly, split into 1-2 doses; see How to Use. Use with labs and diet—consult for tailored plans.

How long does it take to notice the effects of Superbolan 400?

Results depend on the specific compounds included in the blend, but many users report improvements in strength, muscle fullness, recovery, and training performance within the first several weeks.

What are the main benefits of Superbolan 400?

Commonly reported benefits include increased muscle mass, enhanced strength, improved recovery, greater workout intensity, and support for long-term physique development.

What are the possible side effects of Superbolan 400?

Potential side effects may include water retention, acne, oily skin, hormonal suppression, and estrogen-related effects depending on the compounds included in the blend and individual response.

Superbolan 400